- Potential benefitReduces deceptive advertising by forbidding false claims about offering abortion or contraception services.
- Potential benefitEmpowers FTC to take civil enforcement actions including injunctions, restitution, and civil penalties.
- Potential benefitExtends enforcement explicitly to nonprofit organizations that previously evaded FTC jurisdiction.
SAD Act
Read twice and referred to the Committee on Commerce, Science, and Transportation.
The Stop Antiabortion Disinformation Act (SAD Act) prohibits deceptive advertising about reproductive health services, including false claims of providing abortion or contraception or of employing licensed medical personnel. The Federal Trade Commission (FTC) would promulgate rules, enforce violations (including against nonprofits), seek civil remedies, and assess civil penalties up to the greater of $100,000 (inflation-adjusted) or 50% of the ultimate parent's prior-year revenue.
Liberals emphasize protecting patients and curbing misinformation.
Relative to its intended legislative type, this bill is a substantive regulatory statute that clearly defines the targeted problem and embeds enforcement authority within the FTC, but it leaves significant operational detail to future rulemaking and omits fiscal/resourcing acknowledgements.
The Stop Antiabortion Disinformation Act (SAD Act) prohibits deceptive advertising about reproductive health services, including false claims of providing abortion or contraception or of employing licensed medical personnel.
The Federal Trade Commission (FTC) would promulgate rules, enforce violations (including against nonprofits), seek civil remedies, and assess civil penalties up to the greater of $100,000 (inflation-adjusted) or 50% of the ultimate parent's prior-year revenue.
The FTC must report enforcement actions biennially to Congress.
Targeted, administrable consumer-protection approach helps, but abortion controversy, strong penalties, and legal risks make enactment unlikely absent major compromise.
Relative to its intended legislative type, this bill is a substantive regulatory statute that clearly defines the targeted problem and embeds enforcement authority within the FTC, but it leaves significant operational detail to future rulemaking and omits fiscal/resourcing acknowledgements.
Liberals emphasize protecting patients and curbing misinformation.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenCould impose compliance costs and operational burdens on small nonprofits and clinics.
- Potential burdenRisk of chilling speech or counseling, raising First Amendment legal challenges.
- Potential burdenCivil penalty up to 50% of parent company revenue could be punitive and disruptive.
Why the argument around this bill splits.
Liberals emphasize protecting patients and curbing misinformation.
This persona will generally view the bill favorably as a targeted consumer-protection measure to prevent deceptive antiabortion organizations from misleading patients.
They see it as restoring truthful information and protecting access to time-sensitive reproductive care, especially for marginalized communities.
They will welcome explicit inclusion of nonprofits in enforcement.
A pragmatic centrist will see merit in protecting consumers from deceptive health advertising but will be cautious about scope and enforcement design.
They will welcome FTC oversight while seeking narrower definitions, procedural safeguards, and assessment of costs and legal risks.
They will weigh public-health benefits against potential free-speech or regulatory-overreach concerns.
This persona will likely oppose the bill as federal overreach that restricts speech by religious and pro-life organizations and expands administrative power.
They will emphasize free-speech, religious-liberty, and state-primacy concerns, and view large percentage-based penalties as disproportionate.
They will predict aggressive litigation and potential chilling effects on faith-based nonprofits.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Targeted, administrable consumer-protection approach helps, but abortion controversy, strong penalties, and legal risks make enactment unlikely absent major compromise.
- Likelihood and outcome of First Amendment legal challenges
- Judicial interpretation of penalty proportionality and statutory scope
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals emphasize protecting patients and curbing misinformation.
Targeted, administrable consumer-protection approach helps, but abortion controversy, strong penalties, and legal risks make enactment unli…
Relative to its intended legislative type, this bill is a substantive regulatory statute that clearly defines the targeted problem and embeds enforcement authority within the FTC, but it leaves significant operational d…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.